|
Jul 29
|
Should We Be Delighted With Amgen Inc.'s (NASDAQ:AMGN) ROE Of 75%?
|
|
Jul 29
|
NewAmsterdam heart drug hits trial goal, but data appear to disappoint investors
|
|
Jul 25
|
Amgen (AMGN) Stock Moves -0.39%: What You Should Know
|
|
Jul 25
|
Amgen Surges As Weight-Loss Trials Drive Excitement
|
|
Jul 24
|
What Lies in Store for Healthcare ETFs in Q2 Earnings?
|
|
Jun 25
|
Why Amgen (AMGN) Outpaced the Stock Market Today
|
|
Jun 25
|
Top Stock Reports for Chevron, Amgen & Philip Morris
|
|
Jun 25
|
BMS expands Krazati’s FDA label to include colorectal cancer
|
|
Jun 25
|
Biotech ETF (BBH) Hits New 52-Week High
|
|
Jun 21
|
The 30-stock secret: ‘Don’t fight Papa Dow’
|
|
Jun 20
|
Amgen (AMGN) Gains As Market Dips: What You Should Know
|
|
Jun 20
|
Where Will Amgen Be in 5 Years?
|
|
May 11
|
We Wouldn't Be Too Quick To Buy Amgen Inc. (NASDAQ:AMGN) Before It Goes Ex-Dividend
|
|
May 10
|
5 Stocks Driving Dow's Market-Beating Performance
|
|
May 9
|
AMGEN TO PRESENT AT THE BANK OF AMERICA MERRILL LYNCH GLOBAL HEALTHCARE CONFERENCE
|
|
May 9
|
Q1 2024 CytomX Therapeutics Inc Earnings Call
|
|
May 7
|
15 Best S&P 500 Dividend Stocks To Buy Now
|
|
May 6
|
Investors Pile Into Amgen in Search of Next Obesity Drug Payout
|
|
May 3
|
Why Amgen Stock Zoomed Nearly 12% Higher Today
|
|
May 3
|
Amgen's peek at its GLP-1 drug trial results heightens competition in obesity market
|